Pancreastatin is an endogenous peptide that regulates glucose homeostasis

Physiological Genomics

Volumn 45, Issue 22, 2013, Pages 1060-1071

  Valicherla, Guru Raghavendra ^a,b   Hossain, Zakir ^a   Mahata, Sushil K ^c,d   Gayen, Jiaur R ^a,b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Chromogranin A; G protein; Insulin; Pancreastatin; Protein kinase C; Type 2 diabetes

Indexed keywords

CALCIUM; CHROMOGRANIN A; CYCLIC GMP; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HUMAN PANCREASTATIN; INSULIN; LACTIC ACID; LEPTIN; LIPID; NITRIC OXIDE; PANCREASTATIN; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE C BETA3; PROTEIN KINASE C; RECOMBINANT PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADIPOCYTE; ADIPOSE TISSUE; CALCIUM CELL LEVEL; CELL GROWTH; CELL PROLIFERATION; DNA SYNTHESIS; DRUG POTENCY; ENERGY EXPENDITURE; ENERGY METABOLISM; ESSENTIAL HYPERTENSION; FATTY ACID METABOLISM; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HYPOPHYSIS ADENOMA; IC 50; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN SENSITIVITY; LIPOGENESIS; LIVER; LIVER CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STOMACH SECRETION;

CHROMOGRANIN A; G PROTEIN; INSULIN; PANCREASTATIN; PROTEIN KINASE C; TYPE 2 DIABETES;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERTENSION; LIVER; MOLECULAR SEQUENCE DATA; MUSCLE CELLS; MUTATION; PANCREATIC HORMONES; PHYLOGENY; PREGNANCY;

EID: 84887601829     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00131.2013     Document Type: Review

References (89)

1. Adeghate E, Ember Z, Donath T, Pallot DJ, Singh J. Immunohistochemical identification and effects of atrial natriuretic peptide, pancreastatin, leucine-enkephalin, and galanin in the porcine pancreas. Peptides 17: 503-509, 1996.
2. Arden SD, Rutherford NG, Guest PC, Curry WJ, Bailyes EM, Johnston CF, Hutton JC. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem J 298: 521-528, 1994.
3. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005.
4. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312: 446-448, 1984.
5. Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SRJ. The extended granin family: structure, function, and biomedical implications. Endocr Rev 32: 755-797, 2011.
6. Cadman PE, Rao F, Mahata SK, O'Connor DT. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model. Ann NY Acad Sci 971: 528-529, 2006.
7. Carmen GY, Víctor SM. Signalling mechanisms regulating lipolysis. Cell Signal 18: 401-408, 2006.
8. Díaz-Troya S, Najib S, Sánchez-Margalet V. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells. Regul Pept 125: 41-46, 2005.
9. Drees BM, Hamilton JW. Pancreastatin and bovine parathyroid cell secretion. Bone Miner 17: 335-346, 1992.
10. Dupont J, Metayer-Coustard S, Ji B, Rame C, Gespach C, Voy B, Simon J. Characterization of major elements of insulin signaling cascade in chicken adipose tissue: apparent insulin refractoriness. Gen Comp Endocrinol 176: 86-93, 2012.
11. Efendić S, Tatemoto K, Mutt V, Quan C, Chang D, Ostenson CG. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 84: 7257-7260, 1987.
12. Eiden LE. Is chromogranin a prohormone? Nature 325: 301, 1987.
13. Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE, O'Connor DT. Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 98: 148-156, 1996.
14. Fasciotto BH, Gorr SU, Bourdeau AM, Cohn DV. Autocrine regulation of parathyroid secretion: inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and pancreastatin antibodies. Endocrinology 127: 1329-1335, 1990.
15. Fasciotto BH, Gorr SU, Defranco DJ, Levine MA, Cohn DV. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 125: 1617-1622, 1989.
16. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272, 1997.
17. Funakoshi A, Miyasaka K, Kitani K, Tamamura H, Funakoshi S, Yajima H. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochem Biophys Res Commun 158: 844-849, 1989.
18. Funakoshi A, Miyasaka K, Kitani K, Tatemoto K. Effect of pancreastatin on pancreatic endocrine function in the conscious rat. Regul Pept 24: 225-231, 1989.
19. Funakoshi A, Tateishi K, Shinozaki H, Matsumoto M, Wakasugi H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulindependent diabetes mellitus (NIDDM). Regul Pept 30: 159-164, 1990.
20. Funakoshi S, Tamamura H, Ohta M, Yoshizawa K, Funakoshi A, Miyasaka K, Tateishi K, Tatemoto K, Nakano I, Yajima H, Fujii N. Isolation and characterization of a tumor-derived human pancreastatinrelated protein. Biochem Biophys Res Commun 164: 141-148, 1989.
21. Gayen JR, Saberi M, Schenk S, Biswas N, Vaingankar SM, Cheung WW, Najjar SM, O'Connor DT, Bandyopadhyay G, Mahata SK. A novel pathway of insulin sensitivity in chromogranin A null mice. A crucial role for pancreastatin in glucose homeostasis. J Biol Chem 284: 28498-28509, 2009.
22. González-Yanes C, Sánchez-Margalet V. Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes. Biochem Biophys Res Commun 299: 525-531, 2002.
23. Gonzalez-Yanes C, Sanchez-Margalet V. Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes. Cell Mol Life Sci 60: 2749-2756, 2003.
24. González-Yanes C, Sánchez-Margalet V. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes 49: 1288-1294, 2000.
25. González-Yanes C, Sánchez-Margalet V. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. Biochem Biophys Res Commun 289: 282-287, 2001.
26. González-Yanes C, Santos-Alvarez J, Sánchez-Margalet V. Characterization of pancreastatin receptors and signaling in adipocyte membranes. Biochim Biophys Acta 1451: 153-162, 1999.
27. Håkanson R, Chen D, Andersson K, Monstein HJ, Zhao CM, Ryberg B, Sundler F, Mattsson H. The biology and physiology of the ECL cell. Yale J Biol Med 67: 123-134, 1994.
28. Håkanson R, Ding XQ, Norlén P, Chen D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 108: 1445-1452, 1995.
29. Hashimoto T, Kogire M, Lluis F, Gomez G, Tatemoto K, Greeley G Jr, Thompson J. Stimulatory effect of pancreastatin on gastric acid secretion in conscious dogs. Gastroenterology 99: 61-65, 1990.
30. Helle KB. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 79: 769-794, 2004.
31. Hertelendy Z, Patel D, Knittel J. Pancreastatin inhibits insulin secretion in RINm5F cells through obstruction of G-protein mediated, calciumdirected exocytosis. Cell Calcium 19: 125-132, 1996.
32. Herzig KH, Louie DS, Tatemoto K, Chung O. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Am J Physiol Gastrointest Liver Physiol 262: G113-G117, 1992.
33. Huttner WB, Benedum U. Chromogranin A and pancreastatin. Nature 325: 305, 1987.
34. Hutton JC, Nielsen E, Kastern W. The molecular cloning of the chromogranin A-like precursor of β-granin and pancreastatin from the endocrine pancreas. FEBS Lett 236: 269-274, 1988.
35. Keeling A. Engaging people with diabetes in the post-summit world. Diabetes Res Clin Pr 94: 305, 2011.
36. Konecki DS, Benedum UM, Gerdes HH, Huttner W. The primary structure of human chromogranin A and pancreastatin. J Biol Chem 262: 17026-17030, 1987.
37. Lewis J, Zdon M, Adrian T, Modlin I. Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 104: 1031, 1988.
38. Lewis JJ, Goldenring JR, Asher VA, Modlin IM. Pancreastatin: a novel peptide inhibitor of parietal cell signal transduction. Biochem Biophys Res Commun 163: 667-673, 1989.
39. Lindström E, Björkquist M, Boketoft Å, Chen D, Zhao CM, Kimura K, Håkanson R. Release of histamine and pancreastatin from isolated rat stomach ECL cells. Inflamm Res 46: 109-110, 1997.
40. Mahapatra NR, Connor DTO, Vaingankar SM, Hikim APS, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115: 1942-1952, 2005.
41. Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217: 247-257, 1993.
42. Miyasaka K, Funakoshi A, Nakamura R, Kitani K, Shimizu F, Tatemoto K. Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 43: 204-211, 1989.
43. Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata S, Anouar Y. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol 192: 309-324, 2007.
44. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 443: 289-295, 2006.
45. Nakano I, Funakoshi A, Miyasaka K, Ishida K, Makk G, Angwin P, Chang D, Tatemoto K. Isolation and characterization of bovine pancreastatin. Regul Pept 25: 207-213, 1989.
46. O'Connor DT, Cadman PE, Smiley C, Salem RM, Rao F, Smith J, Funk SD, Mahata SK, Mahata M, Wen G. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. J Clin Endocrinol Metab 90: 5414-5425, 2005.
47. Ohneda A, Koizumi F, Ohneda M. Effect of porcine pancreastatin on endocrine function of canine pancreas. Tohoku J Exp Med 159: 291-298, 1989.
48. Peiro E, Miralles P, Silvestre RA, Villanueva ML, Marco J. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism 38: 679-682, 1989.
49. Prévost G, Eas F, Duparc C, Cauliez B, Laquérrière A, Fréger P, Lefebvre H, Kuhn J. Study of the involvement of pancreastatin in the physiopathology of diabetes mellitus associated with nonsecreting pituitary adenomas. Horm Metab Res 42: 861-865, 2012.
50. Sánchez-Margalet V, Goberna R. Pancreastatin activates pertussis-toxin-sensitive guanylate cyclase and pertussis-toxin-insensitive phospholipase C in rat liver membranes. J Cell Biochem 55: 173-181, 1994.
51. Sánchez-Margalet V, Goberna R. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul Pept 51: 215-220, 1994.
52. Sánchez-Margalet V, González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am J Physiol Endocrinol Metab 275: E1055-E1060, 1998.
53. Sánchez-Margalet V, González-Yanes C, Najib S. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells. J Hepatol 35: 80-85, 2001.
54. Sánchez-Margalet V, González-Yanes C, Santos-Alvarez J, Najib S. Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells. Eur J Pharmacol 397: 229-235, 2000.
55. Sánchez-Margalet V, Lobón JA, González A, Fernández-Soto M, Escobar-Jiménez F, Goberna R. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels. Diabetes Care 21: 1951-1954, 1998.
56. Sánchez-Margalet V, Lucas M, Goberna R. Pancreastatin action in the liver: dual coupling to different G proteins. Cell Signal 8: 9-12, 1996.
57. Sánchez-Margalet V, Lucas M, Goberna R. Pancreastatin activates protein kinase C by stimulating the formation of 1, 2-diacylglycerol in rat hepatocytes. Biochem J 303: 51, 1994.
58. + in insulin secreting RINm5F cells. Mol Cell Endocrinol 88: 129-133, 1992.
59. + in rat hepatocytes, involving both pertussis-toxin-sensitive and-insensitive mechanisms. Biochem J 294: 439-442, 1993.
60. Sánchez-Margalet V, Santos-Álvarez J. Solubilization and molecular characterization of active pancreastatin receptors from rat liver membranes. Endocrinology 138: 1712-1718, 1997.
61. Sánchez-Margalet V, Santos-Alvarez J, Díaz-Troya S. Purification of pancreastatin receptor from rat liver membranes. Methods Mol Biol 228: 187-194, 2003.
62. Sanchez-Margalet V, Valle M, Goberna R. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol Pharmacol 46: 24-29, 1994.
63. Sánchez-Margalet V, Valle M, Lobón J, Escobar-Jimenez F, Perez-Cano R, Goberna R. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides 29: 97-101, 1995.
64. Sánchez-Margalet V, Valle M, Lobón JA, Maldonado A, Escobar-Jimenez F, Oliván J, Pérez-Cano R, Goberna R. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. J Hypertens 13: 251-258, 1995.
65. Sanchez V, Calvo JR, Goberna R. Glycogenolytic effect of pancreastatin in the rat. Biosci Rep 10: 87-91, 1990.
66. +-dependent mechanism. Biochem J 284: 659-662, 1992.
67. Santos-Álvarez J, González-Yanes C, Sánchez-Margalet V. Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the Gg/11α family in rat liver membranes. Hepatology 27: 608-614, 1998.
68. Santos-Alvarez J, Sanchez-Margalet V. Pancreastatin activates b3 isoform of phospholipase C via Ga11 protein stimulation in rat liver membranes. Mol Cell Endocrinol 143: 101-106, 1998.
69. Santos-Alvarez J, Sánchez-Margalet V. Affinity purification of pancreastatin receptor-Gq/11 protein complex from rat liver membranes. Arch Biochem Biophys 378: 151-156, 2000.
70. Santos-Álvarez J, Sánchez-Margalet V. G protein Gαq/11 and Gαi1, 2 are activated by pancreastatin receptors in rat liver: studies with GTP-γ35S and azido-GTP-α-32P. J Cell Biochem 73: 469-477, 1999.
71. Schmidt WE, Creutzfeldt W. Pancreastatin-a novel regulatory peptide? Acta Oncol 30: 441-449, 1991.
72. Schmidt WE, Siegel EG, Kratzin H, Creutzfeldt W. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 85: 8231-8235, 1988.
73. Schönfeld JV, Müller MK. The effect of pancreastatin on endocrine and exocrine pancreas. Scand J Gastroenterol 26: 993-999, 1991.
74. Simon-Chazottes D, Wu H, Parmer RJ, Rozansky DJ, Szpirer J, Levan G, Kurtz TW, Szpirer C, Guenet JL, O'Connor DT. Assignment of the chromogranin A (Chga) locus to homologous regions on mouse chromosome 12 and rat chromosome 6. Genomics 17: 252-255, 1993.
75. Simon JP, Aunis D. Biochemistry of the chromogranin A protein family. Biochem J 262: 1, 1989.
76. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 87: 377-389, 1996.
77. Tamamura H, Ohta M, Yoshizawa K, Ono Y, Funakoshi A, Miyasaka K, Tateishi K, Jimi A, Yajima H, Fujii N. Isolation and characterization of a tumor derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48. Eur J Biochem 191: 33-39, 1990.
78. Tatemoto K. Pancreastatin. WO Patent WO/1988/003,536, 1988.
79. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324: 476-478, 1986.
80. Tatemoto K, Mutt V. Chemical determination of polypeptide hormones. Proc Natl Acad Sci USA 75: 4115-4119, 1978.
81. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 348: 1134-1149, 2003.
82. Watkinson A, Jonsson AC, Davison M, Young J, Lee CM, Moore S, Dockray GJ. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem J 276 471-479, 1991.
83. Watkinson A, Rogers M, Dockray G. Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum. Biochem J 295: 649-654, 1993.
84. Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49: 497-528, 1992.
85. Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B, Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel T, Peters C, Bogyo M, Hook V. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci USA 100: 9590-9595, 2003.
86. Zhang J, Fasciotto B, Darling D, Cohn D. Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture. Endocrinology 134: 1310-1316, 1994.
87. Zhang K, Rao F, Wen G, Salem RM, Vaingankar S, Mahata M, Mahapatra NR, Lillie EO, Cadman PE, Friese RS. Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin. Diabetes Obes Metab 8: 621-633, 2006.
88. Zhang T, Mochizuki T, Kogire M, Ishizuka J, Yanaihara N, Thompson JC, Greeley GH. Pancreastatin: characterization of biological activity. Biochem Biophys Res Commun 173: 1157-1160, 1990.
89. Zhao E, Zhang D, Basak A, Trudeau VL. New insights into graninderived peptides: evolution and endocrine roles. Gen Comp Endocrinol 164: 161-174, 2009.